How Can AI Improve Access to Diabetic Retinopathy Screening?

At ENDO 2025, researchers shared a mobile artificial intelligence (AI) tool designed to support diabetic retinopathy screening in a variety of care settings. Their approach focused on making the technology more accessible in places with limited resources. The question below tests your understanding of how AI can help expand access to screening.

©2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.